Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by ABBVIE

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
004125 New Drug Application Approval
005545 New Drug Application Approval
005856 New Drug Application Approval
005932 New Drug Application Approval New manufacturer (S) Standard review drug
006044 New Drug Application Approval
006800 New Drug Application Approval
006905 New Drug Application Approval New formulation (S) Standard review drug
007707 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
008322 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
010021 New Drug Application Approval New manufacturer (S) Standard review drug
010599 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
010796 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
011971 New Drug Application Approval New manufacturer (S) Standard review drug
012003 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
012148 New Drug Application Approval New combination (S) Standard review drug
012302 New Drug Application Approval New ester, new salt, or other noncovalent derivative (P) Priority review drug
012418 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
012524 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
018081 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
018082 New Drug Application Approval New ester, new salt, or other noncovalent derivative; New formulation (P) Priority review drug
018117 New Drug Application Approval New formulation (S) Standard review drug
018279 New Drug Application Approval New formulation (S) Standard review drug
018450 New Drug Application Approval New manufacturer (S) Standard review drug
018651 New Drug Application Approval New molecular entity (NME) (P) Priority review drug (V) Orphan drug
018723 New Drug Application Approval New formulation (S) Standard review drug
018874 New Drug Application Approval New formulation (S) Standard review drug
019204 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
019304 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
019680 New Drug Application Approval New formulation (S) Standard review drug
019946 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020032 New Drug Application Approval New molecular entity (NME) (S) Standard review drug (V) Orphan drug
020098 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
020200 New Drug Application Approval New formulation (S) Standard review drug
020381 New Drug Application Approval New formulation (S) Standard review drug
020478 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020528 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020551 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
020591 New Drug Application Approval New combination (S) Standard review drug
020593 New Drug Application Approval New formulation (S) Standard review drug
020659 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
020716 New Drug Application Approval New combination (S) Standard review drug
020725 New Drug Application Approval Drug already marketed, but without an approved NDA (P) Priority review drug
020738 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020819 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020945 New Drug Application Approval New formulation (S) Standard review drug
021015 New Drug Application Approval New formulation
021168 New Drug Application Approval New formulation (S) Standard review drug
021226 New Drug Application Approval New molecular entity (NME); New combination (P) Priority review drug
021249 New Drug Application Approval New combination (S) Standard review drug
021251 New Drug Application Approval New formulation; New combination (P) Priority review drug
021268 New Drug Application Approval New combination (S) Standard review drug
021402 New Drug Application Approval New manufacturer (S) Standard review drug
021606 New Drug Application Approval New formulation (S) Standard review drug
021656 New Drug Application Approval New manufacturer (S) Standard review drug
021906 New Drug Application Approval New formulation (P) Priority review drug
022078 New Drug Application Approval New combination (S) Standard review drug
022224 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
022309 New Drug Application Approval New formulation (S) Standard review drug
022417 New Drug Application Approval New formulation (S) Standard review drug
040117 Abbreviated New Drug Application Approval
050662 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
050698 New Drug Application Approval New formulation (S) Standard review drug
050739 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
050749 New Drug Application Approval New formulation (S) Standard review drug
050775 New Drug Application Approval New formulation (S) Standard review drug
065003 Abbreviated New Drug Application Approval
065025 Abbreviated New Drug Application Approval
065027 Abbreviated New Drug Application Approval
071295 Abbreviated New Drug Application Approval
074638 Abbreviated New Drug Application Approval
075114 Abbreviated New Drug Application Approval
075729 Abbreviated New Drug Application Approval
087847 Abbreviated New Drug Application Approval
087848 Abbreviated New Drug Application Approval
087853 Abbreviated New Drug Application Approval
088058 Abbreviated New Drug Application Approval
089736 Abbreviated New Drug Application Approval

Back to Companies who have applied for FDA Drug Approval


 

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.